Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Sardar Pasha Sheik Pran Babu"'
Autor:
Sishtla, Kamakshi, Lambert-Cheatham, Nathan, Lee, Bit, Han, Duk Hee, Park, Jaehui, Sardar Pasha, Sheik Pran Babu, Lee, Sanha, Kwon, Sangil, Muniyandi, Anbukkarasi, Park, Bomina, Odell, Noa, Waller, Sydney, Park, Il Yeong, Lee, Soo Jae, Seo, Seung-Yong, Corson, Timothy W.
Publikováno v:
In Cell Chemical Biology 16 June 2022 29(6):1010-1023
Publikováno v:
In Progress in Retinal and Eye Research March 2022 87
Autor:
Park, Bomina1,2 (AUTHOR), Sardar Pasha, Sheik Pran Babu1 (AUTHOR), Sishtla, Kamakshi L.1 (AUTHOR), Hartman, Gabriella D.1,3 (AUTHOR), Qi, Xiaoping4 (AUTHOR), Boulton, Michael E.4 (AUTHOR), Corson, Timothy W.1,2,3,5 (AUTHOR) tcorson@iu.edu
Publikováno v:
International Journal of Molecular Sciences. Dec2022, Vol. 23 Issue 24, p15595. 21p.
Publikováno v:
FASEB J
Ferrochelatase (FECH) is the terminal enzyme in heme biosynthesis. We previously showed that FECH is required for endothelial cell growth in vitro and choroidal neovascularization in vivo. But FECH has not been explored in retinal neovascularization,
Autor:
Song, Hongman, Zeng, Yong, Sardar Pasha, Sheik Pran Babu, Bush, Ronald A, Vijayasarathy, Camasamudram, Qian, Haohua, Wei, Lisa, Wiley, Henry E, Wu, Zhijian, Sieving, Paul A
Publikováno v:
Translational vision science & technology, vol 9, iss 7
PurposeElectric micro-current has been shown to enhance penetration and transduction of adeno-associated viral (AAV) vectors in mouse retina after intravitreal administration. We termed this: "electric-current vector mobility (ECVM)." The present stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::e833915cf53527b56e78456bcc2fbf80
https://escholarship.org/uc/item/3z09j83x
https://escholarship.org/uc/item/3z09j83x
Autor:
Timothy W. Corson, Sardar Pasha Sheik Pran Babu, Samy O. Meroueh, Sayak K. Mitter, Seung-Yong Seo, Wei Sun, Rania S. Sulaiman, Bit Lee, Xiaoping Qi, Yubing Si, Bomina Park, Xiang Fei, Rakshin Kharwadkar, Michael E. Boulton
Publikováno v:
ACS Chemical Biology. 13:45-52
The standard-of-care therapeutics for the treatment of ocular neovascular diseases like wet age-related macular degeneration (AMD) are biologics targeting vascular endothelial growth factor signaling. There are currently no FDA approved small molecul
Autor:
Mehdi Shadmand, Timothy W. Corson, Sameerah Alkhairy, Rania S. Sulaiman, Christian Briggs, Halesha D. Basavarajappa, Seung-Yong Seo, Buyun Tang, Bit Lee, Sardar Pasha Sheik Pran Babu, Kamna Gupta, Michael E. Boulton, Xiaoping Qi, Maria B. Grant, Kamakshi Sishtla, Judith Quigley, Trupti Shetty
Publikováno v:
EMBO Molecular Medicine
Ocular neovascularization underlies major blinding eye diseases such as “wet” age‐related macular degeneration (AMD). Despite the successes of treatments targeting the vascular endothelial growth factor (VEGF) pathway, resistant and refractory
Autor:
Song H; Section for Translational Research on Retinal and Macular Degeneration, National Institute on Deafness and Other Communication Disorders, Bethesda, MD, USA.; National Eye Institute, National Institutes of Health, Bethesda, MD, USA., Zeng Y; Section for Translational Research on Retinal and Macular Degeneration, National Institute on Deafness and Other Communication Disorders, Bethesda, MD, USA.; National Eye Institute, National Institutes of Health, Bethesda, MD, USA., Sardar Pasha SPB; Department of Ophthalmology, School of Medicine, University of California at Davis, Sacramento, CA, USA., Bush RA; Section for Translational Research on Retinal and Macular Degeneration, National Institute on Deafness and Other Communication Disorders, Bethesda, MD, USA.; National Eye Institute, National Institutes of Health, Bethesda, MD, USA., Vijayasarathy C; Section for Translational Research on Retinal and Macular Degeneration, National Institute on Deafness and Other Communication Disorders, Bethesda, MD, USA.; National Eye Institute, National Institutes of Health, Bethesda, MD, USA., Qian H; National Eye Institute, National Institutes of Health, Bethesda, MD, USA., Wei L; National Eye Institute, National Institutes of Health, Bethesda, MD, USA., Wiley HE; National Eye Institute, National Institutes of Health, Bethesda, MD, USA., Wu Z; National Eye Institute, National Institutes of Health, Bethesda, MD, USA., Sieving PA; Section for Translational Research on Retinal and Macular Degeneration, National Institute on Deafness and Other Communication Disorders, Bethesda, MD, USA.; National Eye Institute, National Institutes of Health, Bethesda, MD, USA.; Department of Ophthalmology, School of Medicine, University of California at Davis, Sacramento, CA, USA.
Publikováno v:
Translational vision science & technology [Transl Vis Sci Technol] 2020 Jun 24; Vol. 9 (7), pp. 28. Date of Electronic Publication: 2020 Jun 24 (Print Publication: 2020).
Autor:
Korovina I; Institute for Clinical Chemistry and Laboratory Medicine, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany., Neuwirth A; Institute for Clinical Chemistry and Laboratory Medicine, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany., Sprott D; Institute for Clinical Chemistry and Laboratory Medicine, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany., Weber S; Institute of Pharmacology and Toxicology, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany., Sardar Pasha SPB; Deutsche Forschungsgemeinschaft (DFG) Center for Regenerative Therapies, Center for Molecular and Cellular Bioengineering (CMCB), Technische Universität Dresden, Dresden, Germany., Gercken B; Institute for Clinical Chemistry and Laboratory Medicine, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany., Breier G; Medical Biology, Department of Psychiatry, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany., El-Armouche A; Institute of Pharmacology and Toxicology, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany., Deussen A; Institute of Physiology, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany., Karl MO; Deutsche Forschungsgemeinschaft (DFG) Center for Regenerative Therapies, Center for Molecular and Cellular Bioengineering (CMCB), Technische Universität Dresden, Dresden, Germany.; German Center for Neurodegenerative Diseases (DZNE) Dresden, Dresden, Germany., Wielockx B; Institute for Clinical Chemistry and Laboratory Medicine, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.; Deutsche Forschungsgemeinschaft (DFG) Center for Regenerative Therapies, Center for Molecular and Cellular Bioengineering (CMCB), Technische Universität Dresden, Dresden, Germany., Chavakis T; Institute for Clinical Chemistry and Laboratory Medicine, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany., Klotzsche-von Ameln A; Institute for Clinical Chemistry and Laboratory Medicine, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.; Institute of Physiology, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
Publikováno v:
FASEB journal : official publication of the Federation of American Societies for Experimental Biology [FASEB J] 2019 Feb; Vol. 33 (2), pp. 1758-1770. Date of Electronic Publication: 2018 Aug 29.
Autor:
Sardar Pasha SPB; Eugene and Marilyn Glick Eye Institute, Department of Ophthalmology (S.P.B.S.P., K.S., R.S.S., B.P., T.S., T.W.C.), Department of Pharmacology and Toxicology (R.S.S., B.P., T.S., M.L.F., M.R.K., T.W.C.), Department of Biochemistry and Molecular Biology (M.R.K., T.W.C.), Herman B Wells Center for Pediatric Research, Department of Pediatrics (F.S., M.L.F., M.R.K.), and Melvin and Bren Simon Cancer Center (M.L.F., M.R.K., T.W.C.), Indiana University School of Medicine, Indianapolis, Indiana; and Apexian Pharmaceuticals (J.H.W.), Indianapolis, Indiana., Sishtla K; Eugene and Marilyn Glick Eye Institute, Department of Ophthalmology (S.P.B.S.P., K.S., R.S.S., B.P., T.S., T.W.C.), Department of Pharmacology and Toxicology (R.S.S., B.P., T.S., M.L.F., M.R.K., T.W.C.), Department of Biochemistry and Molecular Biology (M.R.K., T.W.C.), Herman B Wells Center for Pediatric Research, Department of Pediatrics (F.S., M.L.F., M.R.K.), and Melvin and Bren Simon Cancer Center (M.L.F., M.R.K., T.W.C.), Indiana University School of Medicine, Indianapolis, Indiana; and Apexian Pharmaceuticals (J.H.W.), Indianapolis, Indiana., Sulaiman RS; Eugene and Marilyn Glick Eye Institute, Department of Ophthalmology (S.P.B.S.P., K.S., R.S.S., B.P., T.S., T.W.C.), Department of Pharmacology and Toxicology (R.S.S., B.P., T.S., M.L.F., M.R.K., T.W.C.), Department of Biochemistry and Molecular Biology (M.R.K., T.W.C.), Herman B Wells Center for Pediatric Research, Department of Pediatrics (F.S., M.L.F., M.R.K.), and Melvin and Bren Simon Cancer Center (M.L.F., M.R.K., T.W.C.), Indiana University School of Medicine, Indianapolis, Indiana; and Apexian Pharmaceuticals (J.H.W.), Indianapolis, Indiana., Park B; Eugene and Marilyn Glick Eye Institute, Department of Ophthalmology (S.P.B.S.P., K.S., R.S.S., B.P., T.S., T.W.C.), Department of Pharmacology and Toxicology (R.S.S., B.P., T.S., M.L.F., M.R.K., T.W.C.), Department of Biochemistry and Molecular Biology (M.R.K., T.W.C.), Herman B Wells Center for Pediatric Research, Department of Pediatrics (F.S., M.L.F., M.R.K.), and Melvin and Bren Simon Cancer Center (M.L.F., M.R.K., T.W.C.), Indiana University School of Medicine, Indianapolis, Indiana; and Apexian Pharmaceuticals (J.H.W.), Indianapolis, Indiana., Shetty T; Eugene and Marilyn Glick Eye Institute, Department of Ophthalmology (S.P.B.S.P., K.S., R.S.S., B.P., T.S., T.W.C.), Department of Pharmacology and Toxicology (R.S.S., B.P., T.S., M.L.F., M.R.K., T.W.C.), Department of Biochemistry and Molecular Biology (M.R.K., T.W.C.), Herman B Wells Center for Pediatric Research, Department of Pediatrics (F.S., M.L.F., M.R.K.), and Melvin and Bren Simon Cancer Center (M.L.F., M.R.K., T.W.C.), Indiana University School of Medicine, Indianapolis, Indiana; and Apexian Pharmaceuticals (J.H.W.), Indianapolis, Indiana., Shah F; Eugene and Marilyn Glick Eye Institute, Department of Ophthalmology (S.P.B.S.P., K.S., R.S.S., B.P., T.S., T.W.C.), Department of Pharmacology and Toxicology (R.S.S., B.P., T.S., M.L.F., M.R.K., T.W.C.), Department of Biochemistry and Molecular Biology (M.R.K., T.W.C.), Herman B Wells Center for Pediatric Research, Department of Pediatrics (F.S., M.L.F., M.R.K.), and Melvin and Bren Simon Cancer Center (M.L.F., M.R.K., T.W.C.), Indiana University School of Medicine, Indianapolis, Indiana; and Apexian Pharmaceuticals (J.H.W.), Indianapolis, Indiana., Fishel ML; Eugene and Marilyn Glick Eye Institute, Department of Ophthalmology (S.P.B.S.P., K.S., R.S.S., B.P., T.S., T.W.C.), Department of Pharmacology and Toxicology (R.S.S., B.P., T.S., M.L.F., M.R.K., T.W.C.), Department of Biochemistry and Molecular Biology (M.R.K., T.W.C.), Herman B Wells Center for Pediatric Research, Department of Pediatrics (F.S., M.L.F., M.R.K.), and Melvin and Bren Simon Cancer Center (M.L.F., M.R.K., T.W.C.), Indiana University School of Medicine, Indianapolis, Indiana; and Apexian Pharmaceuticals (J.H.W.), Indianapolis, Indiana., Wikel JH; Eugene and Marilyn Glick Eye Institute, Department of Ophthalmology (S.P.B.S.P., K.S., R.S.S., B.P., T.S., T.W.C.), Department of Pharmacology and Toxicology (R.S.S., B.P., T.S., M.L.F., M.R.K., T.W.C.), Department of Biochemistry and Molecular Biology (M.R.K., T.W.C.), Herman B Wells Center for Pediatric Research, Department of Pediatrics (F.S., M.L.F., M.R.K.), and Melvin and Bren Simon Cancer Center (M.L.F., M.R.K., T.W.C.), Indiana University School of Medicine, Indianapolis, Indiana; and Apexian Pharmaceuticals (J.H.W.), Indianapolis, Indiana., Kelley MR; Eugene and Marilyn Glick Eye Institute, Department of Ophthalmology (S.P.B.S.P., K.S., R.S.S., B.P., T.S., T.W.C.), Department of Pharmacology and Toxicology (R.S.S., B.P., T.S., M.L.F., M.R.K., T.W.C.), Department of Biochemistry and Molecular Biology (M.R.K., T.W.C.), Herman B Wells Center for Pediatric Research, Department of Pediatrics (F.S., M.L.F., M.R.K.), and Melvin and Bren Simon Cancer Center (M.L.F., M.R.K., T.W.C.), Indiana University School of Medicine, Indianapolis, Indiana; and Apexian Pharmaceuticals (J.H.W.), Indianapolis, Indiana., Corson TW; Eugene and Marilyn Glick Eye Institute, Department of Ophthalmology (S.P.B.S.P., K.S., R.S.S., B.P., T.S., T.W.C.), Department of Pharmacology and Toxicology (R.S.S., B.P., T.S., M.L.F., M.R.K., T.W.C.), Department of Biochemistry and Molecular Biology (M.R.K., T.W.C.), Herman B Wells Center for Pediatric Research, Department of Pediatrics (F.S., M.L.F., M.R.K.), and Melvin and Bren Simon Cancer Center (M.L.F., M.R.K., T.W.C.), Indiana University School of Medicine, Indianapolis, Indiana; and Apexian Pharmaceuticals (J.H.W.), Indianapolis, Indiana tcorson@iu.edu.
Publikováno v:
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2018 Oct; Vol. 367 (1), pp. 108-118. Date of Electronic Publication: 2018 Aug 03.